Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Montelukast 1%/Naltrexone HCl 0.5%/Zinc Pyrithione 0.2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, Acne, and Rosacea. The gel-like consistency ensures optimal absorption of the active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical gel formulation of Montelukast 1%/Naltrexone HCl 0.5%/Zinc Pyrithione 0.2%. This unique combination of active ingredients has demonstrated efficacy in the management of various skin conditions such as psoriasis, eczema, and atopic dermatitis.
Montelukast, an anti-inflammatory agent, works to alleviate redness, itching, and swelling associated with these skin conditions. Naltrexone HCl, an opioid antagonist, contributes to the reduction of itching and discomfort. Zinc Pyrithione, an antifungal agent, aids in inhibiting the growth of bacteria and fungi on the skin, thereby promoting a healthier skin environment.
This compounded formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment. The gel-like consistency allows for optimal absorption of the active ingredients, enhancing their therapeutic effects.
It is crucial to note that this formulation should not be applied on broken or irritated skin. Potential side effects may include skin irritation or dryness. Always consult with a healthcare professional before starting any new treatment regimen.
If you have any queries about this formulation or how it can assist in managing your skin condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most suitable treatment option tailored to your specific needs.
Montelukast 1%/Naltrexone HCl 0.5%/Zinc Pyrithione 0.2% Topical Gel is a compounded formulation designed for the treatment of skin conditions such as atopic dermatitis, psoriasis, and seborrheic dermatitis. This unique combination of active ingredients works synergistically to alleviate the symptoms associated with these conditions.
Montelukast, an anti-inflammatory agent, helps to reduce inflammation and itching, providing relief from the discomfort these conditions can cause. Naltrexone HCl, an opioid antagonist, further aids in reducing itching and inflammation, enhancing the overall effectiveness of the treatment. Zinc Pyrithione, an antifungal agent, helps to inhibit the growth of fungi and bacteria on the skin, preventing further aggravation of the condition.
This formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients, providing optimal therapeutic benefits.
However, it is crucial to note that this formulation should not be used by patients with a known hypersensitivity to any of the components. It is also not recommended for patients with a history of liver or kidney disease, as it may exacerbate their condition. Patients should be advised to avoid contact with the eyes to prevent potential irritation.
For best results, patients should apply the gel to the affected area twice daily, or as directed by their healthcare provider. Concurrent use of other topical medications on the same area should be avoided as this may increase the risk of side effects.
If you have any questions or concerns about the use of Montelukast 1%/Naltrexone HCl 0.5%/Zinc Pyrithione 0.2% Topical Gel, please do not hesitate to reach out for further information.
Montelukast 1%/Naltrexone HCl 0.5%/Zinc Pyrithione 0.2% Topical Gel is a compounded formulation designed to address a range of skin conditions. This unique blend of active ingredients works synergistically to provide targeted treatment and relief. Montelukast, an anti-inflammatory agent, helps to alleviate redness, swelling, and itching associated with various skin conditions. Naltrexone HCl, an opioid antagonist, aids in reducing the sensation of pain. Lastly, Zinc Pyrithione, an antifungal agent, works to inhibit the growth of fungi on the skin.
This topical gel is particularly beneficial in treating conditions such as eczema, psoriasis, and seborrheic dermatitis. The semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application directly on the affected skin area. It is crucial to use this medication as directed by your healthcare provider for optimal results.
However, it is essential to follow your healthcare provider's instructions when using this medication. If you have any queries or concerns about this formulation or its application, it is recommended to consult with your healthcare provider or a pharmacist.
This is a compounded formulation of three active ingredients: Montelukast, Naltrexone HCl, and Zinc Pyrithione. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin.
The gel has a semisolid, gel-like consistency. This makes it easy to apply and allows for targeted treatment or absorption of the active ingredients.
Apply the gel to the affected area as directed by your healthcare provider. The pump mechanism will dispense the right amount of gel for application.
The active ingredients in this topical gel are Montelukast, Naltrexone HCl, and Zinc Pyrithione. These ingredients work together to provide targeted treatment for various skin conditions.
This topical gel is formulated for specific skin conditions as prescribed by a healthcare provider. It is important to use it as directed and not for other skin conditions without consulting your healthcare provider.
As with any medication, there may be potential side effects. If you experience any unusual symptoms or reactions after applying the gel, contact your healthcare provider immediately.
Store the gel in a cool, dry place away from direct sunlight. Always ensure the cap is tightly closed after use to prevent the gel from drying out.
If you are pregnant or breastfeeding, consult your healthcare provider before using this topical gel. They will be able to advise you based on your specific circumstances and the active ingredients in the gel.
If you miss a dose, apply the gel as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
